MarketFriction

Mukka Proteins Ltd

NSE MUKKA · BSE 544135 · Animal Feed
₹25.70 -1.08%
NSE close2026-10-01
52 week range18.27 - 33.29
Market cap₹783 Cr.
P/E11.3
IPO 2024 · -8% since ESM Price band 5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales332517257172149303382171245654381490
Expenses294498224159140262352157224608347443
Operating Profit381932141041291420453447
OPM %11%3.6%13%8%6%14%8%8%8%7%9%10%
Other Income6853464368152
Interest6678911101113151516
Depreciation333344334455
Profit before tax35172761332029352927
Tax %18%31%-8%5%-40%19%30%33%26%21%26%32%
Net Profit29122951271427272119
EPS in Rs1.280.480.910.140.070.880.450.050.200.790.690.63
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4095496047701,1771,3801,0061,4491,768
Expenses3855255827231,0911,2749121,3351,622
Operating Profit232422488610595115147
OPM %6%4.3%3.6%6%7%8%9%8%8%
Other Income28107819163131
Interest478101625375459
Depreciation25891212141718
Profit before tax1920153666876075100
Tax %27%31%29%28%28%15%20%24%
Net Profit141411264874485774
EPS in Rs1.102.002.341.551.742.31
Dividend Payout %0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%19%7%76%
Compounded Profit Growth%53%6%59%
Stock Price CAGR%%%0%
Return on Equity%17%14%11%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital6662222303030
Reserves38516176126366411469
Borrowings83142159175262365453779
Other Liabilities7495129119166179183343
Total Liabilities2012933553925759411,0761,621
Fixed Assets49787983858594194
CWIP024000931
Investments84122121313756
Other Assets1442092602894698259371,341
Total Assets2012933553925759411,0761,621
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-20-2525-56-150-112-111
Cash from Investing Activity-23-28-14-11-3-48-35-146
Cash from Financing Activity345413157526656267
Net Cash Flow-91281568-9110
Free Cash Flow-39-61-8-1-64-165-130-230
CFO/OP-67%-81%29%22%-52%-118%-114%-84%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days2523292935497246
Inventory Days95891069589136266267
Days Payable6363715651446775
Cash Conversion Cycle5749646873141272238
Working Capital Days4-9-12-110459945
ROCE %15%9%18%24%19%12%12%
Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.33%73.33%73.33%73.33%73.33%73.33%73.33%73.33%73.33%73.33%
FIIs6.46%5.08%2.81%2.63%2.63%2.08%1.70%1.70%1.70%1.73%
DIIs2.00%2.50%2.00%1.98%1.98%1.87%1.66%0.17%0.00%0.00%
Public18.21%19.09%21.84%22.06%22.05%22.71%23.31%24.80%24.97%24.93%
No. of Shareholders1,15,9281,12,0931,44,5491,46,0621,47,3081,45,3431,41,6491,37,9201,32,0981,27,922

Fundamentals

Market Cap₹ 783 Cr.
Current Price₹ 26.3
Stock P/E11.3
Book Value₹ 16.6
ROCE11.6 %
ROE11.1 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)76%
Compounded Profit Growth (TTM)59%
Consolidated figures.
Valuation
Market capRs 771 Cr
Enterprise valueRs 1,009 Cr
P/E (TTM)11.15x
Price to book1.95x
Price to sales0.44x
EV / EBITDA5.69x
EV / EBIT6.34x
EV / sales0.57x
Earnings yield8.97%
P/E, 3-year average15.63x
P/B, 3-year average2.76x
P/E, 5-year average15.63x
P/B, 5-year average2.76x
Profitability
Operating margin (excl. other income)7.64%
Operating margin (incl. other income)9.05%
EBITDA margin10.03%
Pre-tax margin5.66%
Net profit margin3.91%
Net margin, latest quarter3.86%
ROE25.76%
ROCE19.22%
ROA9.24%
ROE, 3-year average30.31%
ROCE, 3-year average20.55%
ROA, 3-year average8.28%
ROE, 5-year average26.35%
ROCE, 5-year average17.86%
ROA, 5-year average6.59%
ROIC (approx.)21.31%
Tax rate15.04%
Other income / net worth4.90%
Growth
Sales growth (latest year)17.22%
Profit growth (latest year)58.92%
Sales CAGR, 3 years31.72%
Sales CAGR, 5 years27.55%
Profit CAGR, 3 years98.32%
Profit CAGR, 5 years37.43%
Sales growth QoQ28.65%
Profit growth QoQ-8.39%
Sales growth YoY (latest quarter)186.73%
Profit growth YoY (latest quarter)1142.76%
Per share
EPS (TTM)Rs 2.30
EPS (latest year)Rs 2.33
EPS (latest quarter)Rs 0.63
EPS, 3-year averageRs 1.81
EPS, 5-year averageRs 81.67
Book value per shareRs 13.20
Sales per shareRs 58.94
Cash flow per shareRs -5.01
Free cash flow per shareRs -7.67
Efficiency
Asset turnover1.47x
Fixed asset turnover16.25x
Inventory turnover2.77x
Inventory days132 days
Debtor days49 days
Debtors turnover7.44x
Creditor days75 days
Cash conversion cycle238 days
Working capital days45 days
Leverage
Total debtRs 365 Cr
Cash and bankRs 127 Cr
Net debtRs 238 Cr
Debt to equity0.92x
Net debt / EBITDA1.35x
Interest coverage2.70x
Current ratio (filing 2026-03-31)1.23x
Quick ratio (filing 2026-03-31)0.41x
Trade payables (filing 2026-03-31)Rs 241 Cr
Owners' fund to total sources42.10%
Debt to assets38.83%
Cash flow
Cash from Operating Activity (latest year)Rs -150 Cr
Cash from Investing Activity (latest year)Rs -48 Cr
Cash from Financing Activity (latest year)Rs 266 Cr
Net Cash Flow (latest year)Rs 68 Cr
Free cash flow (latest year)Rs -230 Cr
FCFE (approx.: FCF + change in debt)Rs -127 Cr
Cash from ops / profit, 5 years-1.68x
Statement figures
Net sales (TTM)Rs 1,768 Cr
Net sales (latest year)Rs 1,380 Cr
Sales (latest quarter)Rs 490 Cr
Operating profit excl. other income (latest year)Rs 105 Cr
Operating profit (latest quarter)Rs 47 Cr
Other income (TTM)Rs 31 Cr
EBITDA (TTM)Rs 177 Cr
PBDT (TTM)Rs 118 Cr
Profit before tax (TTM)Rs 100 Cr
Tax (latest year)Rs 13 Cr
Net profit (TTM)Rs 69 Cr
Net profit (latest year)Rs 70 Cr
Net profit (latest quarter)Rs 19 Cr
Depreciation (TTM)Rs 18 Cr
Depreciation (latest quarter)Rs 5 Cr
Interest (TTM)Rs 59 Cr
Cost of goods sold (latest year)Rs 1,171 Cr
Total expenditure (latest year)Rs 1,274 Cr
Total income (latest year)Rs 1,399 Cr
Share capitalRs 30 Cr
ReservesRs 366 Cr
Shareholders' fundsRs 396 Cr
Total assetsRs 941 Cr
Net blockRs 85 Cr
InvestmentsRs 31 Cr
ReceivablesRs 185 Cr
InventoryRs 423 Cr
Other liabilitiesRs 179 Cr
Shares outstanding (crore)30.00
Ownership
Promoter holding73.33% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 11.2 is at the 3th percentile of its own 2.7-year range (median 17.4, low 10.8, high 122.3).
P/B 1.95 is at the 9th percentile (median 5.77).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodMUKKANifty 50Difference
1 week-5.0%-2.8% -2.2 pts
1 month-3.7%-6.8% +3.0 pts
3 months+7.3%-7.6% +14.9 pts
6 months+39.0%+0.4% +38.6 pts
1 year-4.6%-9.9% +5.3 pts
2 years-40.3%-13.6% -26.8 pts

Red flags

F-score 3 of 8
explainWeak cash conversion Cash from operations was -146% of net profit over the last 3 years
explainHigh accruals Profit exceeded operating cash by 23% of total assets in 2026
explainReceivables outrunning sales Receivables grew 64% vs sales +17% in 2026
lookInventory outrunning sales Inventory grew 84% vs sales +17% in 2026
lookShare dilution Share count up 36% in a year, -100% in three
lookOn NSE surveillance On NSE surveillance: ESM
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹490 Cr +186.5% vs Jun 2025. Net profit ₹19 Cr +850.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Godrej Agrovet Ltd12,15525.919.2 %
Avanti Feeds Ltd10,18418.924.4 %
KSE Ltd57012.433.6 %
Shivam Chemicals Ltd21235.516.6 %
Mayank Cattle Food Ltd11419.015.8 %
Narmada Agrobase Ltd9727.18.95 %
Ajooni Biotech Ltd5413.76.11 %
No bulk or block deals on record.
No corporate actions on record.
DateTypeWhat it says
2026-09-30AcquisitionUpdate on Acquisition
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
ESM: stage 1
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03